The 10 x ’20 Goal – Are We On Track?
![](https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2016/02/10x20-blog-slider-copy-e1455107451132.jpg?resize=640%2C180&ssl=1)
In the last decade (2000-2010), we saw the number of new antibiotic approvals drop successively each year; FDA changed the rules of the approval process without providing public guidance; many antibiotic companies fled the therapeutic area; investments were redirected to Continue reading The 10 x ’20 Goal – Are We On Track?